missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Favipiravir
Description
Favipiravir is a viral RNA polymerase inhibitor; exhibits no effects on mammalian RNA polymerase. Prodrug that is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5'-triphosphate (RTP). Reduces infection rate of SARS-CoV-2 in Vero E6 cells in vitro (IC50 = 61.88 μM). Inhibits influenza virus RNA-dependent RNA polymerase (RdRP) activity (IC50 = 341 nM). Induces lethal mutagenesis in MDCK cells inoculated with seasonal influenza A (H1N1) viruses. Protects mice against Ebola virus.
Spécifications
Spécifications
| Chemical Name or Material | 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide |
| CAS | 259793-96-9 |
| Quantity | 50 mg |
| Target | RNA/DNA Polymerase Inhibitors |
| Molecular Formula | C5H4FN3O2 |
| Purity | 0.98 |